Replies to post #20221 on Momenta Pharmaceuticals, Inc. (MNTA)

[funindasun]

aren’t we many, many years away from this company selling one of their new candidates.?

I think we are looking at '21 M710, '22 M281 HDFN, '23 M281 WaIHA and MG, followed by M254. Their CD34 sifbody and M230 is a long long way off. There's more info in their website.

However, like any other biotech, we know, it is more the promise of their pipeline that moves the stock than the actual approval of drugs. By approval time the rose is off the bloom...

And of course I strongly believe the possibility of EMERGENCY USE on any of their drugs particularly M254. If not for covid-19, it is because of the impending short supply of IVIG.